Please login to the form below

Not currently logged in
Email:
Password:

neuroscience

This page shows the latest neuroscience news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Facing declining sales of older drugs mixed with generic competition, neuroscience specialists Lundbeck has secured a CEO to help reinvigorate the business. ... She brings a wealth of highly successful R&D and commercial experiences including a robust

Latest news

More from news
Approximately 10 fully matching, plus 172 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).

  • Pfizer and IBM's tech-enabled 'Parkinson’s house' Pfizer and IBM's tech-enabled 'Parkinson’s house'

    David Gray, senior neuroscientist at Pfizer’s Neuroscience Research Centre, adds: “One of the reasons we started BlueSky is that we wanted to show that what we are bringing forward is ... Since this article was written Pfizer has substantially scaled

  • Accelerating innovation Accelerating innovation

    Since he joined the French biopharmaceutical company he has seen it sharpen the focus of its research strategy, homing in even more on neuroscience, rare diseases and, especially, cancer.

  • Perfecting the pharmaceutical pipeline with AI Perfecting the pharmaceutical pipeline with AI

    Together with the Sheffield Institute of Translational Neuroscience at Sheffield University, a world authority on ALS, we are now testing some of these hypotheses in the lab.

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    It also recently launched neuroscience company Cerevance in Cambridge, Massachusetts in partnership with Lightstone Ventures, with the 25-person research team coming from Takeda’s Cambridge UK site.

More from intelligence
Approximately 2 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics